Charlie McGarel-Groves

Partner
Joined firm 2014. Partner since 2021.

Charlie advises public and private institutions, corporates and sponsors on a broad range of financing matters covering debt capital markets, securitisations, derivatives and structured products, acquisition finance, leveraged and investment grade loans, complex security and collateral arrangements, and repackagings.

Highlights

Highlights include advising:

  • on acquisition financings including Wren House Infrastructure's acquisition of North Sea Midstream Partners, HH Global’s acquisition of InnerWorkings, Novo Nordisk’s acquisition of Emisphere Technologie and GlaxoSmithKline on the financing of its acquisition of TESARO, Inc
  • UK Asset Resolution on various stages of the wind-down of its investments in Bradford & Bingley and NRAM
  • HM Treasury on the establishment of the COVID Corporate Financing Facility, a key element of the Government’s response to the economic impacts of the COVID pandemic
  • Walmart on the £3.8 billion buy-out of the ASDA Pension Scheme with Rothesay Life
  • ASDA on the £2.75 billion bond offering in connection with its sale by Walmart to the Issa brothers and TDR capital
  • Novo Nordisk on the establishment of its EUR 5 billion Euro Medium Term Note programme and the first issuances under that programme with an aggregate principal amount of EUR 1.3 billion